Pricing Log in Create free account
Friday 6 November 2026 Export KNSA’s income statement to Excel — free account

Kiniksa Pharmaceuticals International, plc

KNSA Healthcare Drug Manufacturers Specialty & Generic

Kiniksa Pharmaceuticals International, plc’s revenue for fiscal 2025 (year ended December 2025) was $677.6 million, up 60.1% from fiscal 2024.

Revenue
+58.1%
EPS
+142.2%
Free cash flow
+43.5%

Quarter to September 2026, against a year earlier

88.50 7.62 −7.93%
Market cap
$6.9B
P/E
62.1×
Fwd P/E
67.8×
Dividend yield
—
F-score
8/9
Altman Z
10.35
Beneish M
−3.16
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Kiniksa Pharmaceuticals International, plc (KNSA) Current ratio

Alert me on Current ratio

Kiniksa Pharmaceuticals International, plc's current ratio at the end of the quarter to 30 September 2026 was 3.9×, up 0.1× from fiscal 2025 (3.8×). Over the past ten years it has ranged from 2.7× (fiscal 2017) to 24.5× (fiscal 2016); the current reading is higher than 30% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 2.4× and above the Healthcare sector median of 3.1×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 3.8× 14.86%
FY2024 3.3× (24.02%)
FY2023 4.3× (15.96%)
FY2022 5.2× 17.83%
FY2021 4.4× (58.12%)
FY2020 10.5× 20.53%
FY2019 8.7× 17.76%
FY2018 7.4× 172.82%
FY2017 2.7× (88.96%)
FY2016 24.5× —

Quarterly newest first

Period Current ratio Change
Sep 2026 3.9× 0.13%
Jun 2026 3.9× 2.92%
Mar 2026 3.8× 0.17%
Dec 2025 3.8× (1.56%)
31 more quarters

Against its own ten years

Low 2.7× High 24.5×
Ten-year median 4.8×
Current reading's percentile 30

Current ratio against peers

Company Current ratio
KNSA Kiniksa Pharmaceuticals International, plc 3.9×
LNTH Lantheus Holdings, Inc. compare 3.2×
ALKS Alkermes plc compare 2.4×
LQDA Liquidia Corporation compare 2.3×
ELAN Elanco Animal Health Incorporated compare 2.1×
RDY Dr. Reddy's Laboratories Ltd compare 1.9×
AMRX AMNEAL PHARMACEUTICALS, INC. compare 1.9×
HIMS Hims & Hers Health, Inc. compare 0.9×
SUPN Indivior Pharmaceuticals Inc. compare 0.6×
Drug Manufacturers Specialty & Generic industry median 2.4×
Healthcare sector median 3.1×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on KNSA